Zizhen Ming - Search Results

Year	Number of Results
2014	1
2019	1
2020	2
2021	1
2022	4
2023	4
2024	1

1

The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.

Lim SY, Shklovskaya E, Lee JH, Pedersen B, Stewart A, Ming Z, Irvine M, Shivalingam B, Saw RPM, Menzies AM, Carlino MS, Scolyer RA, Long GV, Rizos H. Lim SY, et al. Among authors: ming z. Nat Commun. 2023 Mar 18;14(1):1516. doi: 10.1038/s41467-023-36979-y. Nat Commun. 2023. PMID: 36934113 Free PMC article.

2

A Critical Role for CARD9 in Intestinal Microbiota Modulation and Colorectal Malignancies.

Luo P, Ming Z, Yang Z. Luo P, et al. Among authors: ming z. Front Biosci (Landmark Ed). 2022 Dec 7;27(12):320. doi: 10.31083/j.fbl2712320. Front Biosci (Landmark Ed). 2022. PMID: 36624940 Free article. Review.

3

Melanoma Cell State-Specific Responses to TNFα.

Lim SY, Alavi S, Ming Z, Shklovskaya E, Fung C, Stewart A, Rizos H. Lim SY, et al. Among authors: ming z. Biomedicines. 2021 May 26;9(6):605. doi: 10.3390/biomedicines9060605. Biomedicines. 2021. PMID: 34073253 Free PMC article.

4

Genetic Alterations in the INK4a/ARF Locus: Effects on Melanoma Development and Progression.

Ming Z, Lim SY, Rizos H. Ming Z, et al. Biomolecules. 2020 Oct 15;10(10):1447. doi: 10.3390/biom10101447. Biomolecules. 2020. PMID: 33076392 Free PMC article. Review.

5

IFN-γ Signaling Sensitizes Melanoma Cells to BH3 Mimetics.

Ming Z, Lim SY, Stewart A, Pedersen B, Shklovskaya E, Menzies AM, Carlino MS, Kefford RF, Lee JH, Scolyer RA, Long GV, Rizos H. Ming Z, et al. J Invest Dermatol. 2023 Jul;143(7):1246-1256.e8. doi: 10.1016/j.jid.2023.01.017. Epub 2023 Feb 1. J Invest Dermatol. 2023. PMID: 36736995

6

Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling.

Park JJ, Stewart A, Irvine M, Pedersen B, Ming Z, Carlino MS, Diefenbach RJ, Rizos H. Park JJ, et al. Among authors: ming z. Cancer Gene Ther. 2022 Oct;29(10):1384-1393. doi: 10.1038/s41417-022-00457-2. Epub 2022 Mar 29. Cancer Gene Ther. 2022. PMID: 35352024 Free PMC article.

7

Ex vivo tissue modelling informs drug selection for rare cancers.

Lee JH, Ming Z, Cheung VKY, Pedersen B, Wykes JJ, Palme CE, Clark JJ, Gupta R, Rizos H. Lee JH, et al. Among authors: ming z. Int J Cancer. 2024 Apr 1;154(7):1158-1163. doi: 10.1002/ijc.34802. Epub 2023 Dec 7. Int J Cancer. 2024. PMID: 38059815

8

A microfluidic immunosensor based on magnetic separation for rapid detection of okadaic acid in marine shellfish.

Ji Y, Cai G, Liang C, Gao Z, Lin W, Ming Z, Feng S, Zhao H. Ji Y, et al. Among authors: ming z. Anal Chim Acta. 2023 Jan 25;1239:340737. doi: 10.1016/j.aca.2022.340737. Epub 2022 Dec 21. Anal Chim Acta. 2023. PMID: 36628732

9

Mitogen-activated protein kinase dependency in BRAF/RAS wild-type melanoma: A rationale for combination inhibitors.

Ming Z, Lim SY, Kefford RF, Rizos H. Ming Z, et al. Pigment Cell Melanoma Res. 2020 Mar;33(2):345-357. doi: 10.1111/pcmr.12824. Epub 2019 Sep 25. Pigment Cell Melanoma Res. 2020. PMID: 31518489

10

Durable Responses to Anti-PD1 and Anti-CTLA4 in a Preclinical Model of Melanoma Displaying Key Immunotherapy Response Biomarkers.

Shklovskaya E, Pedersen B, Stewart A, Simpson JOG, Ming Z, Irvine M, Scolyer RA, Long GV, Rizos H. Shklovskaya E, et al. Among authors: ming z. Cancers (Basel). 2022 Oct 3;14(19):4830. doi: 10.3390/cancers14194830. Cancers (Basel). 2022. PMID: 36230753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year